A Single-Center Retrospective Comparison of Doxorubicin-Loaded HepaSphere Transarterial Chemoembolization with Conventional Transarterial Chemoembolization for Patients with Unresectable Hepatocellular Carcinoma

KÜÇÜKAY F., Badem S., Karan A., Ozdemir M., Okten R. S., Ozbulbul N. I., ...More

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, vol.26, no.11, pp.1622-1629, 2015 (SCI-Expanded) identifier identifier identifier


Purpose: To compare doxorubicin-loaded HepaSphere transarterial chemoembolization versus conventional transarterial chemoembolization in terms of survival, time to recurrence, acute reversible hepatotoxicity, postembolization syndrome, and chemoembolization-related mortality and morbidity.